| International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ... Journal of thoracic oncology 6 (2), 244-285, 2011 | 6196 | 2011 |
| The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification WD Travis, E Brambilla, AG Nicholson, Y Yatabe, JHM Austin, ... Journal of thoracic oncology 10 (9), 1243-1260, 2015 | 4928 | 2015 |
| Comprehensive molecular profiling of lung adenocarcinoma Cancer Genome Atlas Research Network Nature 511 (7511), 543, 2014 | 4893* | 2014 |
| The landscape of somatic copy-number alteration across human cancers R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ... Nature 463 (7283), 899-905, 2010 | 4472 | 2010 |
| The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ... Journal of Thoracic Oncology 11 (1), 39-51, 2016 | 4454 | 2016 |
| Comprehensive genomic characterization of squamous cell lung cancers CGAR Network Nature 489 (7417), 519-25, 2012 | 3818 | 2012 |
| Vinorelbine plus cisplatin vs. observation in resected non–small-cell lung cancer T Winton, R Livingston, D Johnson, J Rigas, M Johnston, C Butts, ... New England Journal of Medicine 352 (25), 2589-2597, 2005 | 2344 | 2005 |
| Erlotinib in lung cancer—molecular and clinical predictors of outcome MS Tsao, A Sakurada, JC Cutz, CQ Zhu, S Kamel-Reid, J Squire, ... New England Journal of Medicine 353 (2), 133-144, 2005 | 2321 | 2005 |
| Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ... Nature 491 (7424), 399-405, 2012 | 2268 | 2012 |
| Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation KP Hoeflich, J Luo, EA Rubie, MS Tsao, OU Jin, JR Woodgett Nature 406 (6791), 86-90, 2000 | 1834 | 2000 |
| Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American … NI Lindeman, PT Cagle, DL Aisner, ME Arcila, MB Beasley, EH Bernicker, ... Archives of pathology & laboratory medicine 142 (3), 321-346, 2018 | 1632 | 2018 |
| Probability of cancer in pulmonary nodules detected on first screening CT A McWilliams, MC Tammemagi, JR Mayo, H Roberts, G Liu, K Soghrati, ... New England journal of medicine 369 (10), 910-919, 2013 | 1423 | 2013 |
| PD-L1 immunohistochemistry assays for lung cancer: results from phase 1 of the blueprint PD-L1 IHC assay comparison project FR Hirsch, A McElhinny, D Stanforth, J Ranger-Moore, M Jansson, ... Journal of Thoracic Oncology 12 (2), 208-222, 2017 | 1327 | 2017 |
| Characterizing the cancer genome in lung adenocarcinoma BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ... Nature 450 (7171), 893-898, 2007 | 1300 | 2007 |
| Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas JD Campbell, A Alexandrov, J Kim, J Wala, AH Berger, CS Pedamallu, ... Nature genetics 48 (6), 607-616, 2016 | 1214 | 2016 |
| Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study Nature medicine 14 (8), 822-827, 2008 | 1147 | 2008 |
| SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas AJ Bass, H Watanabe, CH Mermel, S Yu, S Perner, RG Verhaak, SY Kim, ... Nature genetics 41 (11), 1238-1242, 2009 | 1094 | 2009 |
| PD-L1 as a biomarker of response to immune-checkpoint inhibitors DB Doroshow, S Bhalla, MB Beasley, LM Sholl, KM Kerr, S Gnjatic, ... Nature reviews Clinical oncology 18 (6), 345-362, 2021 | 1057 | 2021 |
| EGFR mutations and lung cancer G da Cunha Santos, FA Shepherd, MS Tsao Annual Review of Pathology: Mechanisms of Disease 6 (1), 49-69, 2011 | 983 | 2011 |
| An overview of the c-MET signaling pathway SL Organ, MS Tsao Therapeutic advances in medical oncology 3 (1_suppl), S7-S19, 2011 | 981 | 2011 |
Natasha LeighlMedical Oncology, Princess MargaretVerified email at uhn.ca
